Dyne Therapeutics, Inc. (DYN)
17.46
-0.31
(-1.74%)
USD |
NASDAQ |
Jan 12, 16:00
17.44
-0.02
(-0.09%)
After-Hours: 20:00
Dyne Therapeutics Research and Development Expense (Quarterly): 97.22M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Avidity Biosciences, Inc. | 154.95M |
| MannKind Corp. | 14.06M |
| Sarepta Therapeutics, Inc. | 218.89M |
| Denali Therapeutics, Inc. | 101.95M |
| Kymera Therapeutics, Inc. | 71.94M |